Search alternatives:
significant interaction » significant reduction (Expand Search), significant attention (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
interaction terms » interaction tests (Expand Search), interaction patterns (Expand Search), interaction networks (Expand Search)
significant interaction » significant reduction (Expand Search), significant attention (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
interaction terms » interaction tests (Expand Search), interaction patterns (Expand Search), interaction networks (Expand Search)
-
2081
-
2082
-
2083
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2084
-
2085
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2086
-
2087
-
2088
-
2089
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2090
-
2091
-
2092
-
2093
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2094
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2095
-
2096
-
2097
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2098
-
2099
-
2100